Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1
Closed 138
2018
Q3
$0 Hold
1
﹤0.01% 610
2018
Q2
$0 Sell
1
-2,826
-100% -$160K ﹤0.01% 571
2018
Q1
$169K Sell
2,827
-66
-2% -$4.4K 0.02% 123
2017
Q4
$228K Buy
+2,893
New +$233K 0.04% 100

Other funds holding ADNT

Trilogy Capital's ADNT Position: Q4 2018 in Review

Trilogy Capital sold out of Adient (ADNT) in Q4 2018, closing a stake of 1 share.

Trilogy Capital first reported a position in ADNT in Q4 2017 and held it in 4 quarters. The position peaked at $228K in Q4 2017. 347 funds tracked by Wall St. Rank hold ADNT as of Q4 2018.

  • Trilogy Capital reported no remaining Adient position as of Q4 2018 after selling out during the quarter.
  • Trilogy Capital sold 1 Adient share in Q4 2018.
  • Trilogy Capital first reported a position in Adient in Q4 2017 and held it in 4 quarters.
  • Trilogy Capital's Adient position peaked at $228K in Q4 2017.
  • 347 funds tracked by Wall St. Rank held Adient as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.